<DOC>
	<DOCNO>NCT01238367</DOCNO>
	<brief_summary>This trial conduct Japan . The aim clinical trial investigate pharmacokinetics ( effect investigate drug body ) safety turoctocog alfa ( recombinant factor VIII ( N8 ) ) Japanese subject haemophilia A .</brief_summary>
	<brief_title>A Single Dose Trial Recombinant Factor VIII ( N8 ) Japanese Subjects With Haemophilia A : An Extension Trial NN7008-3543</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Japanese subject complete NN70083543 No detectable inhibitor factor VIII Congenital acquire coagulation disorder haemophilia A Planned surgery trial period Receipt investigational drug recombinant factor VIII ( N8 ) within 30 day trial product administration</criteria>
	<gender>Male</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>66 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>